Metformin + Saxagliptin
Composition
This formulation contain combination of Metformin and Saxagliptin as active agents
Indications
used to treat type 2 diabetes mellitus in adults
Side effects
gastrointestinal disturbances (such as nausea, diarrhea, or abdominal discomfort), headache, upper respiratory tract infections
Precautions
Use caution in patients with a history of pancreatitis, renal impairment, or heart failure. Saxagliptin may increase the risk of heart failure
Contraindications
Contraindications include hypersensitivity as well as diabetic ketoacidosis, severe renal impairment, and heart failure.
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai